Coreline Soft Secures AI Imaging Contracts with NHS and Boehringer Ingelheim

Coreline Soft secures AI imaging contracts with NHS and Boehringer Ingelheim, enhancing medical image analysis in healthcare. 🏥📊

🌟 Stay Updated!
Join AI Health Hub to receive the latest insights in health and AI.

Coreline Soft, a South Korean developer of imaging AI, has successfully secured multiple supply contracts across the UK, Europe, and Taiwan.

NHS Partnership: Coreline Soft has signed its first contract with the UK’s National Health Service (NHS) to provide its AI-powered medical image analysis software, AVIEW, for the Eastern Diagnostic Imaging Network project. This initiative will see the software implemented in 12 hospitals, including Cambridge University Hospital, focusing on health screenings and general CT examinations.
French National Cancer Institute: The company has been appointed as the exclusive provider of AI image analysis software for the national lung cancer screening project by the Institut National du Cancer in France. Hospitals such as Assistance Publique – Hôpitaux de Paris and Lyon City Hospital will utilize Coreline Soft’s solution, which can identify pulmonary nodules, emphysema, and coronary artery calcification from a single chest CT scan.
Boehringer Ingelheim Taiwan: Coreline Soft will supply its AI software module for detecting lung deformation patterns to partner hospitals of Boehringer Ingelheim Taiwan. This module will assist in identifying patients with interstitial lung disease for clinical trials of Ofev (nintedanib) and the investigational drug nerandomilast.

VUNO’s Regulatory Approvals: Another South Korean company, VUNO, has received the EU Medical Device Regulation certification and the UKCA mark for its AI cardiac arrest risk assessment tool. This will facilitate its expansion into the Middle East.
AITRICS Approval in Hong Kong: AITRICS has gained medical device approval from the Hong Kong government for its AI software that predicts patient deterioration risks, marking its fourth regulatory approval globally.
Aevice Health’s 510(k) Clearance: Singapore-based Aevice Health has obtained the US FDA’s 510(k) clearance for its smart wearable stethoscope, now approved for use in children aged 3 and above.